Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Guardant Health Inc (NQ: GH ) 24.61 -0.48 (-1.91%) Streaming Delayed Price Updated: 12:41 PM EDT, Sep 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 239,921 Open 25.23 Bid (Size) 24.58 (3) Ask (Size) 24.61 (3) Prev. Close 25.09 Today's Range 24.44 - 25.31 52wk Range 15.81 - 37.04 Shares Outstanding 101,298,669 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long September 18, 2024 From Guardant Health, Inc. Via Business Wire Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session September 17, 2024 Via Benzinga Performance YTD -7.17% -7.17% 1 Month -15.20% -15.20% 3 Month -15.40% -15.40% 6 Month +43.67% +43.67% 1 Year -6.28% -6.28% More News Read More iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session September 16, 2024 Via Benzinga Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket September 16, 2024 Via Benzinga Key Takeaways From Guardant Health Analyst Ratings August 08, 2024 Via Benzinga Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types September 13, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy September 10, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 27, 2024 From Guardant Health, Inc. Via Business Wire Why Guardant Health Stock Just Crashed 10% August 26, 2024 Via The Motley Fool PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session August 26, 2024 Via Benzinga Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) August 23, 2024 Via AB Newswire Exposures COVID-19 Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought August 23, 2024 Via The Motley Fool Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening August 22, 2024 From Guardant Health, Inc. Via Business Wire Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought August 12, 2024 Via The Motley Fool Cathie Wood's Ark Invest Continues Loads Up On $6.05M Worth Of Robinhood Shares Amid Bitcoin Rebound, Dumps Zoom Stock August 08, 2024 Via Benzinga Guardant Health to Participate in Upcoming Investor Conferences August 08, 2024 From Guardant Health, Inc. Via Business Wire GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q2 2024 August 07, 2024 Via InvestorPlace Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance August 07, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer August 07, 2024 From Guardant Health, Inc. Via Business Wire Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat August 01, 2024 Via Investor's Business Daily Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer August 01, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies August 01, 2024 From Guardant Health, Inc. Via Business Wire Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought July 31, 2024 Via The Motley Fool FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption July 29, 2024 Via Benzinga Exposures Product Safety Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening July 29, 2024 From Guardant Health, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
